These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, Mouthon L, Guillevin L, Meyer O, Ekindjian OG, Weber S, Kahan A. Arthritis Rheum; 2008 Jan 12; 58(1):284-91. PubMed ID: 18163505 [Abstract] [Full Text] [Related]
11. Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis. Ciurzyński M, Bienias P, Lichodziejewska B, Kurnicka K, Szewczyk A, Glińska-Wielochowska M, Kurzyna M, Błaszczyk M, Liszewska-Pfejfer D, Pruszczyk P. Clin Rheumatol; 2008 Aug 12; 27(8):991-7. PubMed ID: 18256871 [Abstract] [Full Text] [Related]
13. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Fijalkowska A, Kurzyna M, Torbicki A, Szewczyk G, Florczyk M, Pruszczyk P, Szturmowicz M. Chest; 2006 May 12; 129(5):1313-21. PubMed ID: 16685024 [Abstract] [Full Text] [Related]
14. N-terminal probrain natriuretic peptide as a biochemical marker in the evaluation of bosentan treatment in systemic-sclerosis-related pulmonary arterial hypertension. Dimitroulas T, Giannakoulas G, Karvounis H, Koliakos G, Sfetsios T, Dimitroula H, Settas L. Clin Rheumatol; 2008 May 12; 27(5):655-8. PubMed ID: 18204995 [Abstract] [Full Text] [Related]
15. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide. Avouac J, Meune C, Chenevier-Gobeaux C, Borderie D, Lefevre G, Kahan A, Allanore Y. Arthritis Care Res (Hoboken); 2015 Jul 12; 67(7):1022-30. PubMed ID: 25604469 [Abstract] [Full Text] [Related]